Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 09, 10:48
Statera BioPharma Total Liabilities (Quarterly): 22.92M for Sept. 30, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 22.92M |
| June 30, 2022 | 20.46M |
| March 31, 2022 | 15.94M |
| December 31, 2021 | 22.68M |
| Date | Value |
|---|---|
| September 30, 2021 | 23.84M |
| June 30, 2021 | 35.72M |
| March 31, 2021 | 5.422M |
| December 31, 2020 | 4.691M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.691M
Minimum
Dec 2020
35.72M
Maximum
Jun 2021
18.96M
Average
21.57M
Median
Total Liabilities (Quarterly) Benchmarks
| Humanigen Inc | 54.84M |
| Cantabio Pharmaceuticals Inc | 2.215M |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | 69.08M |
| Scopus BioPharma Inc | 11.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.75M |
| Shareholders Equity (Quarterly) | -10.24M |